G. Frezza

2.0k citations
17 papers · 1.5k indexed · 1 hit paper · h-index 12

G. Frezza

17 papers receiving 1.4k citations

Hit Papers

MGMT Promoter Methylation Status Can Predict the Incidenc...6342008202620142020200400600

Peers

G. Frezza
Comparison fields: 5 of 72
  • Genetics 1.0k
  • Radiology, Nuclear Medicine and Imaging 472
  • Pulmonary and Respiratory Medicine 593
  • Cancer Research 209
  • Pathology and Forensic Medicine 207
Replace B. Fisher with:
B. Fisher Canada
Steven J. DiBiase United States
Dong Soo Lee South Korea
Vishwa Jeet Amatya Japan
Beatrice Detti Italy
Y. Tsukada United States
Natascha Döbert Germany
Fausto Zorzi Italy
Mika Watanabe Japan
Brian Haylock United Kingdom
G. Frezza relative to B. Fisher Canada B. Fisher's profile →
Citations per field
00.5×1.5×
B. Fisher · 1×
Citations per year

Countries citing papers authored by G. Frezza

Since Specialization
Citations

This map shows the geographic impact of G. Frezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Frezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Frezza more than expected).

Fields of papers citing papers by G. Frezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Frezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Frezza. The network helps show where G. Frezza may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Frezza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Frezza Line = papers co-authored together G. Frezza links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 2009289
2 2008201
3
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patientsbreakdown →
2008634
4 200410
5 1999124
6
Radiotherapy in vertebral tumors. Indications and limits: a report on 28 cases of Ewing's sarcoma of the spine.
199816
7 199748
8
Localized orbital lymphoma.
199749
9 199626
10 199510
11
[Extramedullary plasmocytoma (EMP) of the head and neck: a series of 22 cases].
199511
12
[Radiotherapy of stage T1 carcinoma of the glottis. Analysis of prognostic factors in 154 patients].
19953
13 19946
14 199216
15 19911
16 198627
17 198313

About G. Frezza

G. Frezza is a scholar working on Genetics, Otorhinolaryngology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Viral-associated cancers and disorders (4 papers), Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (4 papers), Sarcoma Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Vascular Tumors and Angiosarcomas (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Genetics (1.0k citations), Radiology, Nuclear Medicine and Imaging (472 citations), Pulmonary and Respiratory Medicine (593 citations), Cancer Research (209 citations) and Pathology and Forensic Medicine (207 citations). G. Frezza has collaborated with scholars based in Italy and United States. Frequent co-authors include Alicia Tosoni, F. Spagnolli, Alba A. Brandes, Enrico Franceschi, Mario Ermani, Marco Leonardi, Fabio Calbucci, Giovanni Tallini, Annalisa Pession and V. Blatt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Radiotherapy and Oncology and Journal of Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026